Beijing R&D and Pilot Base
Formulation, analytical evaluation, process research, pilot scale-up and development-batch preparation.

MICRONEEDLE DRUG DELIVERY PLATFORM
An end-to-end transdermal delivery solution provider, from formulation development to scalable manufacturing.
CASMN: MICRONEEDLE DEVELOPMENT & MANUFACTURING PLATFORM
Founded in 2018, Beijing CAS Microneedle Technology Co., Ltd. is a technology commercialization enterprise originating from the Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences.
CASMN provides feasibility assessment, formulation development, process optimization, pilot scale-up and manufacturing support for pharmaceutical, biotechnology, medical-device and healthcare partners.
COMPANY PROFILE
The company video introduces the Beijing R&D and pilot base, Chongqing manufacturing base and integrated technology services.
Serving Life Science & Healthcare Innovators
FOUR INTEGRATED SOLUTIONS
01Formulation, evaluation, pilot scale-up and clinical-batch support.
Explore this solution →
02Device design, registration support, validation and manufacturing.
Explore this solution →
03Product planning, formulation, efficacy testing and volume production.
Explore this solution →
04Laboratory forming equipment and customizable precision molds.
Explore this solution →Integrated Project Delivery
Formulation, analytical evaluation, process research, pilot scale-up and development-batch preparation.
Quality systems, compliant manufacturing and scalable capacity supporting commercial delivery.
CORE TECHNOLOGY PLATFORM


Rapid release from a drug-coated microneedle surface.
Water-soluble matrices carry and release active ingredients.
Hydrogel pathways support transdermal delivery and intact removal.
Enterprise Certifications and Intellectual Property


















Company Milestones
START A MICRONEEDLE PROJECT